Newsletter

MALAYSIA: Introduction of the Automated Re-Registration Route in MeDC@St 2.0+ for Streamlined Market Access and Continuous Supply of Medical Devices – July/August 2026

MALAYSIA: Introduction of the Automated Re-Registration Route in MeDC@St 2.0+ for Streamlined Market Access and Continuous Supply of Medical Devices – July/August 2026

  • 2026-08-25 07:50:09

The Medical Device Authority (MDA) of Malaysia has announced the new Automated Re-Registration Route within the MeDC@St 2.0+ platform, effective from 13 July 2026. This initiative aims to support continuous product availability, reducing administrative workload, and improving regulatory efficiency while maintaining compliance with existing MDA requirements.

More
QT Activity: Webinar Recap I Unlocking ANZ Market Access: Australia TGA Updates & New Zealand Entry Made Simple – June/July 2026

QT Activity: Webinar Recap I Unlocking ANZ Market Access: Australia TGA Updates & New Zealand Entry Made Simple – June/July 2026

  • 2026-07-27 04:05:50

Qualtech's recent webinar provided practical insights into medical device market entry in Australia and New Zealand, covering Australia's ARTG inclusion process, post-market obligations, new UDI requirements, and New Zealand's WAND notification framework. The session also highlighted key regulatory updates and practical considerations for manufacturers planning expansion into the ANZ market.

More
Qualtech Webinar: Unlocking ANZ Market Access – Australia TGA Updates & New Zealand Entry Made Simple – June 2026

Qualtech Webinar: Unlocking ANZ Market Access – Australia TGA Updates & New Zealand Entry Made Simple – June 2026

  • 2026-05-29 07:54:15

Join Qualtech's free webinar on June 18, 2026, to explore the latest regulatory developments and market access considerations for Australia and New Zealand. This session will provide practical insights into Australia TGA application pathways, key TGA updates in 2026, and the current regulatory framework in New Zealand, helping medical device manufacturers better prepare their ANZ market entry strategies.

More
Australia: Australia Aligns with US FDA Standards: Faster Market Access for Class IIa and III Devices – December/January 2025

Australia: Australia Aligns with US FDA Standards: Faster Market Access for Class IIa and III Devices – December/January 2025

  • 2024-12-16 09:17:34

The updated Therapeutic Goods regulations in Australia, effective October 19, 2024, introduce streamlined documentation for medical devices assessed by the US FDA. By aligning with international standards, the changes simplify compliance for Class IIa and Class III devices, reducing burdens while ensuring safety and quality, offering manufacturers faster market access.

More